Covid Vaccine

ARCT-154, also known as VBC-COV19-154 in Vietnam, is a COVID-19 vaccine candidate developed by Arcturus Therapeutics.

Read more in the app

A New Way to Inspire People to Get a COVID Vaccine

Is the Novavax COVID Vaccine Better than mRNA Vaccines? What We Know So Far

Researchers Who Made COVID Vaccine Possible Awarded Nobel Prize

FDA Panel Recommends a Covid Vaccine Aimed at Only the XBB Variant

New Research Uncovers Potential Explanation for COVID Vaccine Blood Clot Connection

AstraZeneca’s Covid Vaccine May Have Posed a Higher Heart Risk for Young Women, Study Shows

Study examines heart inflammation after COVID vaccine

After Long Delay, Moderna Pays N.I.H. for Covid Vaccine Technique

Kizzmekia Corbett Unlocked the Science of the Covid Vaccine

Covid Vaccine Makers Kept Prepayments for Canceled Shots for Poor Nations

InnovationRx: Health System Quality; Plus, A Yearly Covid Vaccine

Key Partner in Covax Will Stop Giving Free Vaccines to Middle-Income Nations

New Research: Your Choice of COVID Vaccine Can Increase Your Risk of Myocarditis

Which COVID vaccine you get can impact myocarditis risk

Intranasal COVID vaccine that works against variants in animals

Cancer vaccine may be ready by 2030, say COVID vaccine makers

The World's First Needle-Free COVID Vaccine Just Got Approved in China

Three Covid Vaccine Doses Better Than Two Against Omicron Infections, New Study Reinforces

Moderna Sues Pfizer and BioNTech Over Covid Vaccine Technology

Distress leads to higher COVID vaccine rates, less adherence to distancing guidelines, study finds